Influx Healthtech IPO GMP, Review, Price, Allotment

0
Should You Grab Influx Healthtech IPO at ₹91, 22% GMP? Detailed Review InsideInflux Healthtech IPO Allotment
Influx Healthtech IPO GMP

Influx Healthtech IPO description – Influx Healthtech, a Mumbai-based company specializing in healthcare products, has established itself as a key player in contract manufacturing, serving as a third-party manufacturer. The company operates three manufacturing facilities in Thane, Maharashtra, with areas of approximately 6,500 square feet, 13,000 square feet, and 14,000 square feet. These plants are certified with GMP, HACCP, ISO 22000, and Halal standards, and are equipped with advanced machinery, a dedicated quality control department, and a skilled workforce.

The company specializes in several segments, including dietary and nutritional supplements, cosmetics, ayurvedic/herbal products, veterinary feed supplements, and homecare items. Additionally, Influx Healthcare produces active pharmaceutical ingredients (API) used in the formulation of tablets, capsules, and injectables.

Their client portfolio for the CDMO business includes prominent brands such as Bling Brands, Pursuit of Wellness, Aarkios Health, HSHS Nutraceuticals, Novus Life Science, Bruder Life Science, Fredun Pharmaceuticals, and BigFlex Lifescience. For Fiscal Year 2024, the production capacities of Unit 1, Unit 2, and Unit 3 are 1,100 kg, 1,700 kg, and 7,300 kg, respectively. Influx Healthcare employs 165 permanent staff on payroll.

Influx Healthtech IPO Allotment Status

Promoters of Influx Healthtech – Mr. Munir Abdul Ganee Chandniwala, Ms. Shirin Munir Ahmed Chandniwala, and Mr. Abdul Ganee Abdul Rasul Chandniwala


Influx Healthtech IPO Details

Influx Healthtech IPO Dates18 – 20 June 2025
Influx Healthtech Issue PriceINR 91 – 96 per share
Fresh issue50,00,400 shares (INR 45.50 – 48 crore)
Offer For Sale11,00,400 shares (INR 10.01 – 10.56 crore)
Total IPO size61,00,800 shares (INR 55.52 – 58.57 crore)
Minimum bid (lot size)1,200 shares (INR 1,15,200)
Face Value INR 10 per share
Retail Allocation35%
Listing OnNSE EMERGE

Influx Healthtech Financial Performance

 FY 2023FY 2024FY 2025
Revenue76.0699.97104.85
Expenses66.3285.0887.11
Net income7.2011.1313.37
Figures in INR Crores unless specified otherwise

Influx Healthtech Offer News


Influx Healthtech Valuations & Margins

FY 2023FY 2024FY 2025
EPS3.966.137.36
PE ratio12.36 – 13.04
RONW (%)61.7648.8536.98
NAV6.4212.5519.91
ROCE (%)78.6065.5849.17
EBITDA (%)14.1016.9619.62
Debt/Equity 0.070.010.01
*Compiled by IPO Central from Prospectus

Influx Healthtech IPO GMP Today

DateConsolidated IPO GMPKostakSubject to Sauda
24 June 20252522,000
23 June 20252522,000
21 June 20254037,000
20 June 20254037,000
19 June 20254239,000
18 June 20253835,000
17 June 20253531,000
16 June 20252120,000
14 June 20252120,000
13 June 202517–16,000

Influx Healthtech IPO Objectives

The company proposes to utilize the Net Proceeds from the Fresh Issue towards funding the following objects:

  • Funding capital expenditure requirements for setting up of manufacturing facility for Nutraceutical Division â€“ INR 22.49 crore
  • Funding capital expenditure requirements for setting up of manufacturing facility for Veterinary Food Division â€“ INR 11.49 crore
  • Purchase of Machineries for Homecare and Cosmetic Division â€“ INR 2.76 crore
  • General Corporate Purpose

Influx Healthtech IPO Subscription – Live Updates

CategoryQIBNIIRetailTotal
Shares Offered11,59,2008,70,00020,29,20040,58,400
20 Jun 2025137.87481.47117.70201.44
19 Jun 20251.6932.5835.7325.33
18 Jun 20251.465.778.275.79

The market maker reservation portion of 3,06,000 shares and anchor investor portion of 17,36,400 shares are not included in the above calculations.


Influx Healthtech â€“ Comparison With Listed Peers

CompanyPE ratioEPSRONW (%)Book ValueRevenue (Cr.)
Influx Healthtech12.36 – 13.047.3636.9819.91104.99
Sudarshan Pharma48.280.6612.455.305,053.84
Quest Laboratories10.388.2816.5849.921,081.59

Influx Healthtech IPO Dates & Listing Performance

IPO Opening Date18 June 2025
IPO Closing Date20 June 2025
Finalization of Basis of Allotment23 June 2025
Initiation of refunds24 June 2025
Transfer of shares to demat accounts24 June 2025
IPO Listing Date25 June 2025
Opening Price on NSE SMEINR 132.50 per share (up 38.02%)
Closing Price on NSE SMEINR 126.20 per share (up 31.46%)

Influx Healthtech Offer Lead Manager

RAREVER FINANCIAL ADVISORS PRIVATE LIMITED
807, Iconic Shyamal, Shyamal Cross Road, 132 Ring Road,
Satellite, Manekbag, Ahmedabad, Gujarat, 380015 India
Phone: 079-4925 8260 / +91-99981 23745
Email[email protected]
Website: www.rarever.in


Influx Healthtech Offer Registrar

MAASHITLA SECURITIES PRIVATE LIMITED
451, Krishna Apra Business Square,
Netaji Subhash Place, Pitampura, Delhi – 110034
Phone: +91-11-47581432
Email: [email protected]
Website: www.maashitla.com


Influx Healthtech Issue Contact Details

INFLUX HEALTHTECH LIMITED
109, Ghanshyam Enclave Premises,
Co-op Soc Plot No. 856, Laljipada, Kandivali West,
Mumbai 400067, Maharashtra, India
Phone: +91 7045997809
E-mail: [email protected]
Website: www.influxhealthtech.com


IPO FAQs

What is Influx Healthtech offer size?

Influx Healthtech offer size is INR 55.52 – 58.57 crores.

What is Influx Healthtech offer price band?

Influx Healthtech public offer price is INR 91 – 96 per share.

What is the lot size of Influx Healthtech IPO?

Influx Healthtech offer lot size is 1,200 shares.

What is Influx Healthtech IPO GMP today?

Influx Healthtech IPO GMP today is INR 25 per share.

What is Influx Healthtech kostak rate today?

Influx Healthtech kostak rate today is INR NA per application.

What is Influx Healthtech Subject to Sauda rate today?

Influx Healthtech’s Subject to Sauda rate today is INR 22,000 per application.

LEAVE A REPLY

Please enter your comment!
Please enter your name here